A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: The Treatment of Early Aggressive Rheumatoid Arthritis trial, Arthritis & Rheumatism, vol.69, issue.Suppl, pp.2824-2859, 2012. ,
DOI : 10.1002/art.34498
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update, Annals of the Rheumatic Diseases, vol.69, issue.(Suppl), pp.2013-204573, 2013. ,
DOI : 10.1136/annrheumdis-2013-204573
Infliximab for 6???months added on combination therapy in early rheumatoid arthritis: 2-year results from an investigator-initiated, randomised, double-blind, placebo-controlled study (the NEO-RACo Study), Annals of the Rheumatic Diseases, vol.72, issue.6, pp.851-858, 2013. ,
DOI : 10.1136/annrheumdis-2012-201365
Drug survival on TNF inhibitors in patients with rheumatoid arthritis comparison of adalimumab, etanercept and infliximab, Annals of the Rheumatic Diseases, vol.64, issue.(Suppl 2), 2013. ,
DOI : 10.1136/annrheumdis-2013-204128
A cost-effectiveness analysis of treatment options for patients with methotrexate-resistant rheumatoid arthritis, Arthritis & Rheumatism, vol.44, issue.10, pp.2316-2343, 2000. ,
DOI : 10.1002/1529-0131(200010)43:10<2316::AID-ANR20>3.0.CO;2-6
Cost-utility analysis of treatment strategies in patients with recent-onset rheumatoid arthritis, Arthritis Care Res, vol.61, issue.3, pp.291-300, 2009. ,
Patient-reported outcomes in a randomized trial comparing four different treatment strategies in recent-onset rheumatoid arthritis, Arthritis Care & Research, vol.67, issue.2 Suppl 1, pp.4-12, 2008. ,
DOI : 10.1002/art.24367